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Abstract: Guillain-Barré syndrome (GBS) is reported frequently following hepatotrophic viruses, but its
occurrence due to the hepatitis A virus has been rarely reported to date. We present a case of serologically
positive acute hepatitis A infection associated with GBS. There was an increased protein level in the
cerebrospinal fluid and prolonged nerve conduction, with minimal axonal damage findings in
electromyography.
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Özet: Guillain-Barré sendromu (GBS) hepatotrofik virüsleri takiben s›k rapor edilmiﬂtir, ancak hepatit A
virüsüne ba¤l› olan› nadirdir. Biz serolojik olarak pozitif akut hepatit A enfeksiyonu ve GBS olan bir hastay›
sunuyoruz. Serebrospinal s›v›da artm›ﬂ protein düzeyleri, uzam›ﬂ sinir yan›t› ve elektromiyografide minimal
aksonal hasar bulgular› mevcuttu.
Anahtar Sözcükler: Guillain-Barré sendromu, akut hepatit A, elektromiyografi

Introduction
Guillain-Barré syndrome (GBS) is an inflammatory postinfectious disease. It is a lifethreatening disease, characterized by polyneuritis associated with symmetrically ascending
motor weakness (1-8). Neurological symptoms appear 1-3 weeks after a viral infection or
immunization (3). It has been shown that viral agents such as the Epstein-Barr virus, HIV
and the cytomegalovirus are responsible for the etiopathogenesis of GBS in the majority
of cases (8). However, to date, reports of GBS caused by hepatitis A have been exceedingly
rare. We present a case of GBS due to hepatitis A.
Case report
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A 22-year-old man presented with progressive ascending weakness and distal
paresthesia in all extremities. His history revealed a serologically positive acute hepatitis
A infection 2 weeks previously. His neurological complaints started 10 days after the
viral infection. His initial neurological complaint was paresthesia in the distal region of
both legs; 1 day later weakness appeared in the distal muscles, which progressed to
quadriparesis in 3 days. On physical examination his blood pressure was 120/80 mmHg,
heart rate 82/min rhythmic, temperature 36.5 °C, and there was slight icterus over the
body, but there was no organomegaly, tender liver, respiratory insufficiency or
circulatory abnormalities. On neurological examination generalized weakness in all
extremities was observed, along with diffuse areflexia and glove and stocking type
hypoesthesia. Mental status and sphincter functions were normal. Plantar reflexes were
flexor.
A routine blood test showed normal renal function, electrolytes, glucose and
hematological values. Serum level of alanine aminotransferase (ALT) was 181 IU/l
(normal < 40 IU/l), serum aspartate aminotransferase (AST) 116 IU/l (normal < 40 IU/l)
and total bilirubin 1.6 mg/dl (normal < 1 mg/dl). Serum IgM antibodies against hepatitis
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A were positive. Cerebrospinal fluid protein level was 66
mg/dl (normal: 15-45 mg/dl) with no cells. Nerve
conduction velocities in peripheral nerves were prolonged
with slightly decreased axonal amplitudes in
electroneuromyography (ENMG).
Intravenous Ig G (IVIG) therapy was planned, but it
was not started because of financial factors. Prednisolone
750 mg/day intravenous was given for 5 days as well as
supporting therapy. Motor weakness recovered totally
and paresthesia was partially improved within a month.

Discussion
GBS is the most common cause of generalized
paralysis. Although its etiology is unclear, the majority of
GBS cases develop following a viral infection (9-11).
Hepatitis A is regarded as the most benign form of viral
hepatitis. Additionally, despite the fact that hepatitis A is
the most frequent type of hepatitis disease, GBS due to
hepatitis A and C is seldom reported. Since hepatitis
infection is seen more frequently in young people, GBS is
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seen also in young adults and almost all cases were
reported during the acute period of hepatitis (3,8).
The etiogenesis of GBS with hepatitis is unknown, but
it is considered that the direct cytotoxicity of the virus or
immune-mediated damage and molecular resemblance
between hepatitis A and myelin structures of peripheral
nerves may be responsible for this entity (3,8,9).
General therapy methods for GBS can be also used for
GBS patients with hepatitis (6). However, liver enzymes
should be continuously monitored, especially after
medication is started. Immunoglobulins should be the
first choice in the treatment of this disease, because of
the lower risk for hepatic side effects and because it is the
most effective agent. However, steroid and
plasmapheresis may be also tried as an alternative
therapy (6). The prognosis is good in GBS due to hepatitis
A and almost all patients are cured, as was our patient.
In conclusion, although only a few cases of GBS due to
hepatitis A have been reported to date, this complication
should be kept in mind as hepatitis A is not always benign.
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